|
Second-line tivantinib (ARQ 197) vs placebo in patients (Pts) with MET-high hepatocellular carcinoma (HCC): Results of the METIV-HCC phase III trial. |
|
|
Consulting or Advisory Role - Bayer; Italfarmaco; Lilly; Sirtex Medical |
Travel, Accommodations, Expenses - ArQule |
Other Relationship - Amgen |
|
|
Honoraria - Celgene; Novartis |
Consulting or Advisory Role - Bayer; Ipsen; Pfizer |
Research Funding - Bayer; Celgene |
Travel, Accommodations, Expenses - Bayer; Ipsen; Novartis |
|
Markus Peck-Radosavljevic |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bayer |
|
Travel, Accommodations, Expenses - Bayer |
|
|
Consulting or Advisory Role - Neo Therma |
Research Funding - ArQule (Inst); Exelixis (Inst); Halozyme (Inst); Nordion (Inst); Polaris (Inst) |
Travel, Accommodations, Expenses - Halozyme |
|
|
Honoraria - Bayer; Bristol-Myers Squibb; Sirtex Medical |
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Sirtex Medical |
Speakers' Bureau - Bayer; Lilly |
|
Travel, Accommodations, Expenses - Bayer; Lilly |
|
|
Consulting or Advisory Role - Bayer |
|
|
Honoraria - Daiichi Sankyo (I); Sirtex Medical |
Consulting or Advisory Role - Amgen; Bayer; Celgene |
|
|
|
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck Sharp & Dohme |
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Celgene |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen; Novartis; Peloton Therapeutics; Pfizer |
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer |
Research Funding - Pfizer (Inst) |
|
|
|
Speakers' Bureau - BTG/Bayer |
|
|
|
Stock and Other Ownership Interests - ArQule |
|
|
|
|
Stock and Other Ownership Interests - ArQule |
|
|
|
Stock and Other Ownership Interests - ArQule |
|
|
Employment - Daiichi Sankyo |
Stock and Other Ownership Interests - Daiichi Sankyo |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Abbvie; ArQule; ArQule; Bayer; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; BTG; BTG; Gilead Sciences; Kowa; Novartis; Novartis; Onxeo; Onxeo; OSI Pharmaceuticals; OSI Pharmaceuticals; Roche; Roche; TERUMO; TERUMO |
Speakers' Bureau - Bayer; BTG; TERUMO |
|